Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 17,500 | |||
5 mg | 在庫あり | ¥ 37,500 | |||
10 mg | 在庫あり | ¥ 60,500 | |||
25 mg | 在庫あり | ¥ 121,500 | |||
50 mg | 在庫あり | ¥ 176,500 | |||
100 mg | 在庫あり | ¥ 248,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 36,500 |
説明 | ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease. |
ターゲット&IC50 | Glucocerebrosidase:0.4 μM (EC50) |
分子量 | 290.32 |
分子式 | C17H14N4O |
CAS No. | 1380716-06-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.9 mg/ml (10 mM), Sonication is recommended.
H2O: Insoluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML198 1380716-06-2 Metabolism Glucokinase inhibit ML 198 GCase modulator Inhibitor Non-inhibitory chaperone ML-198 Gaucher disease Glucosidase Glucocerebrosidase inhibitor